Luteolin ameliorates ferric nitrilotriacetic acid induced renal toxicity and tumor promotional response in rat

Indian Journal of Experimental Biology

Volumn 47, Issue 5, 2009, Pages 355-360

  Sultana, Sarwat ^a   Prasad, Lakshmi ^a   Jahangir, Tamanna ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cell proliferation response; Chemoprevention; Ferric nitrilotriacetate; Luteolin

Indexed keywords

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANTINEOPLASTIC AGENT; CARCINOGEN; LUTEOLIN; NITRILOTRIACETIC ACID;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; KIDNEY; KIDNEY TUMOR; MALE; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; KIDNEY; KIDNEY NEOPLASMS; LUTEOLIN; MALE; NITRILOTRIACETIC ACID; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 67651043170     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. (Pubitemid 28532456) Bravo L, Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev, 56 (11) (1998) 317.
2. (Pubitemid 32107405) Shimoi K, Saka N, Kaji K, Nozawa R and Kinae N, Metabolic fate of luteolin and its functional activity at focal site, Biofactors, 12 (1-4) (2000) 181.
3. Kim H K, Cheon B S, Kim S Y and Kim H P, Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure activity relationship, Biochem pharmacol, 58 (1999) 759.
4. (Pubitemid 34775302) Sartor L, Pezzato E, Dell'Aica I, Caniato R, Biggin S and Garbisa S, Inhibition of matrix-proteases by polyphenols: Chemical insights for anti-inflammatory and anti-invasion drug design, Biochem Pharmacol, 64 (2) (2002) 229.
5. Goddard J G, Basford D and Sweeney G D, Lipid peroxidation stimulated by iron nitrilotriacetate in rat liver, Biochem Pharmacol, 35 (14) (1986) 2381.
6. Goddard J G and Sweeney G D, Ferric nitrilotriacetate: A potent stimulant of in vivo lipid peroxidation in mice, Biochem Pharmacol, 32 (24) (1983) 3879.
7. Bacon B R, Tavill A S, Brittenham G M, Park C H and Recknagel R O, Hepatic lipid peroxidation in vivo in rats with chronic iron overload, J Clin Invest, 71 (3) (1983) 429.
8. (Pubitemid 16072534) Hamazaki S, Okada S, Ebina Y, Fujioka M and Midorikawa O, Nephrotoxicity of ferric nitrilotriacetate, An electronmicroscopic and metabolic study, Am J Pathol, 123 (2) (1986) 343.
9. (Pubitemid 15038217) Anderson R L, Bishop W E and Campbell R, Review of the environment and mammalian toxicology of nitrilotriacetic acid, Crit Rev Toxicol, 15 (1985) 1.
10. (Pubitemid 28134715) Kawabata T, Ma Y, Yamador I and Okada S, Iron-induced apoptosis in mouse renal proximal tubules after an injection of a renal carcinogen, iron-nitrilotriacetate, Carcinogenesis, 18 (7) (1997) 1389.
11. (Pubitemid 19170859) Hamazaki S, Okada S, Li J L, Toyokuni S and Midorikawa O, Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate, Arch Biochem Biophys, 272 (1) (1989) 10.
12. Liu M, Okada S and Kawabata T, Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: Comparison with other iron chelate complexes, Acta Medica Okayama, 45 (6) (1991) 401.
13. Valenzuela A, Fernandez V and Videla L A, Hepatic and biliary levels of glutathione and lipid peroxides following iron overload in the rat: effect of simultaneous ethanol administration, Toxicol Appl Pharmacol, 70 (1) (1983) 87.
14. (Pubitemid 20333719) Umemura T, Sai K, Takagi A, Hasegawa R and Kurokawa Y, Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in the rat kidney after ferric nitrilotriacetate administration, Cancer Lett, 54 (1-2) (1990) 95.
15. (Pubitemid 9201266) Awai M, Narasaki M, Yamanoi Y and Seno S, Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate, A model of experimental hemochromatosis. Am J Pathol, 95 (3) (1979) 663.
16. Jollow D J, Mitchell J R, Zampaglione N and Gillette J R, Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobezene oxide as the hepatotoxic metabolite, Pharmacology, 11 (1974) 151.
17. Habig W H, Pubst M J and Jokoby W B, GST the first enzymatic step in mercapturic acid formation, J Biol Chem, 249 (1974) 7130.
18. Carlberg B, Mannervik, Glutathione level in rat brain, J. Biol Chem, 250 (1975) 4480-575.
19. Wright J R, Colby H D and Miles P R, Cytosolic factors which affect microsomal lipid peroxidation in lung and liver, Arch Biochem Biophys, 206 (1981) 296.
20. Kanter M W, Clinical chemistry (The Bobber Merill Company Inc., USA) 1975, 80.
21. Hare R S, Endogenous creatinine in serum and urine, Proc. Soc. Exp. Biol. Med, 74 (1950) 148.
22. (Pubitemid 11096681) Pick A and Keisari Y, Superoxide anion and H2O2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimulus, Cell Immun, 59 (1981) 301.
23. Zaheer N, Tiwari K K and Krishnan P S, Exposure and solubilization of hepatic mitochondrial shunt dehydrogrnases, Arch Biochem Biophys, 109 (1965) 646.
24. Mohandas J, Marshall J J, Duggin G G, Horvath J S and Tiller D, Differential distribution of glutathione and glutathione related enzymes in rabbit kidney, Cancer Res, 44 (1984) 5086.
25. O'Brien T G, Simsiman R C and Boutwell R K, Induction of the polyamine biosynthesis enzymes in mouse epidermis by tumor promoting agents, Cancer Res, 35 (1975) 1662.
26. Smart R C, Huang M T and Conney A H, Sn 1, 2-diacylglycerols mimic the effects of TPA in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis, Carcinogenesis, 7 (1986) 1865.
27. Giles K W and Myers A, An improved diphenylamine method for the estimation of deoxyribonucleic acid, Nature, 206 (1965) 63.
28. Lowry O H, Rosebrough NJ, Farr A L and Randall R J, Protein measurement with the phenol reagent, J. Biol Chem, 193 (1951) 265.
29. (Pubitemid 351836127) Rudolf E, Andelova H and Cervinka M, Polyphenolic coumpounds in chemoprevention of colon cancer targets and signaling pathways, Anticancer Agents Med Chem, 7 (5) (2007) 559.
30. (Pubitemid 40127572) Horvathova K, Chalupa I, Sebova L, Tothova D and Vachalkova A, Protective effect of quercetin and luteolin in human melanoma HMB-2 cells, Mutat Res, 565 (2) (2005) 105.
31. Coles B and Ketterer B, The role of glutathione and glutathione transferases in chemical carcinogenesis, C. Rev. Biochem. Mol. Biol, 25 (1) (1990) 47.
32. Hartman P E and Shankel D M, Antimutagens and anticarcinogens: A survey of putative interceptor molecules, Environ Mol Mutagen, 15 (3) (1990) 145.
33. (Pubitemid 28454257) Ketterer B, Glutathione S-transferases and prevention of cellular free radical damage, Free Radic Res, 28 (6) (1998) 647.
34. DeLeve L D, Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation, Hepatology, 24 (4) (1996) 830.
35. Vanoni M A, Edmondson D E, Zanetti G and Curti B, Characterization of the flavins and the iron-sulfur centers of glutamate synthase from Azospirillum brasilense by absorption, circular dichroism, and electron paramagnetic resonance spectroscopies, Biochemistry, 31 (19) (1992) 4613.
36. Meister A, Glutathione, in The liver, Biology and pathobiology, edited by I. M. Arias, J L. Boyer, W. B Jacoby, D. Fausto, D. Schacter and D. A. Shafirtz (Raven Press, New York) 1994, 401.
37. Sun Y, Free radicals, antioxidant enzymes and carcinogenesis, Free Radic Biol Med, 8 (1990) 583-599.
38. (Pubitemid 18276843) De Flora S and Ramel C, Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res, 202 (2) (1988) 285-306.